Martha Sklavos, PhD, PMP Joins Arcellx as new Senior Director, Program Management

Published on : July 23, 2020July 23, 2020 Published by : Jeff Caskey

Dr. Sklavos joins Arcellx with over 15 years of experience in biomedical and clinical research in academic, government and industry settings. Dr. Sklavos brings broad drug development expertise to Arcellx as a result of managing multiple complex projects and portfolios comprised of various drug modalities including monoclonal and bispecific antibodies, antibody drug conjugates, peptide conjugates, and cell therapies.

David Auerbach is the newly appointed Head of Business Projects – Oncology R&D Business Planning & Operations at AstraZeneca

Published on : July 21, 2020July 21, 2020 Published by : Chris Frew

David Auerbach is the newly appointed Head of Business Projects – Oncology R&D Business Planning & Operations at AstraZeneca

BroadOak Capital Partners Appoints Bryan Poltilove as Managing Director

Published on : July 6, 2020July 8, 2020 Published by : Chris Frew

Bryan Poltilove is a Managing Director focused on guiding BroadOak’s growth capital investing strategy and advising portfolio companies in the life sciences and cell and gene therapy sectors.

Mark Aldridge joins Workforce Genetics as a Senior Life Sciences Talent Consultant

Published on : July 6, 2020July 8, 2020 Published by : Chris Frew

Mark Aldridge joins Workforce Genetics as a Senior Life Sciences Talent Consultant to support the growth and expansion of the business in the Greater Philadelphia region.

Erica Gourdine Joins Workforce Genetics to Support Growing Biotech Practice

Published on : June 30, 2020June 30, 2020 Published by : Chris Frew

Erica Gourdine, Life Science Recruiter at Workforce Genetics.

MacroGenics Appoints Dr. Stephen Eck As Chief Medical Officer

Published on : June 17, 2020June 17, 2020 Published by : Chris Frew

MacroGenics Appoints Dr. Stephen Eck As Chief Medical Officer Rockville, MD, June 16, 2020 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based [….]

Novovax announced that Silvia Taylor, MBA, has joined the company as SVP, Investor Relations, and Corporate Affairs

Published on : June 17, 2020June 17, 2020 Published by : Chris Frew

Novovax announced that Silvia Taylor, MBA, has joined the company as SVP, Investor Relations, and Corporate Affairs GAITHERSBURG, Md., June 17, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing [….]

Novavax Appoints Biotechnology Veteran David Mott to Board of Directors

David Mott Board of Directors of Novavax

Published on : June 17, 2020June 17, 2020 Published by : Chris Frew

Novavax Appoints Biotechnology Veteran David Mott to Board of Directors GAITHERSBURG, Md., June 16, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today [….]

Nick Fullenkamp Appointed Chief Business Officer at Avidea Technologies, Inc.

Published on : June 3, 2020June 3, 2020 Published by : Chris Frew

Nick Fullenkamp Appointed Chief Business Officer at Avidea Technologies, Inc. Nick Fullenkamp, M.B.A. has joined Avidea Technologies as Chief Business Officer and will be leading Business Development, financing strategy and [….]

Ulyana Desiderio joins the Maryland Department of Commerce as Director of BioHealth and Life Sciences

Published on : May 8, 2020May 8, 2020 Published by : Chris Frew

Ulyana Desiderio joins the Maryland Department of Commerce as Director of BioHealth and Life Sciences Ulyana Desiderio joined the Department of Commerce in April 2020 as Director of BioHealth and Life [….]